HDFC Pharma and Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1568 Cr | ₹1208 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹100 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 04 Oct 2023 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare Index | Nifty Pharma TRI |
Turn Over | % | 26.49% |
Expense Ratio | 2.14 | 2.14 |
Manager | Dhruv Muchhal | Meeta Shetty |
ISIN Code | INF179KC1HL7 | INF277K016A9 |
Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | -7.92% | -8.17% |
6 Month | -4.61% | -10.97% |
1 Year | 23.89% | 9.76% |
3 Year | - | 19.8% |
5 Year | - | 22.63% |
SIP Return Analysis
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | -7.48% | -9.97% |
1 Year | 5.84% | -7.58% |
3 Year | - | 21.18% |
5 Year | - | 18.31% |
Rolling Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 51.48% | 7.82% |
3 Year | - | 17.79% |
5 Year | - | 14.55% |
Risk Management
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | - | 15.471% |
Sharp | - | 0.874% |
Beta | - | 0.953% |
Alpha | - | 0.602% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Dhruv Muchhal | Meeta Shetty |
Total AUM | ₹520687 Cr | ₹17847 Cr |
Fund Manage | 40 | 5 |
HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 4.17063 | 5.05855 |
Small Cap | 34.62211 | 27.81853 |
Large Cap | 35.27771 | 35.25534 |
Mid Cap | 25.92957 | 31.86756 |
Sector Allocation
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 2.46783 | 4.33978 |
Basic Materials | 2.03973 | 2.22397 |
Healthcare | 95.49246 | 93.43623 |
Top Comparisons
UTI Flexi Cap Fund - Growth Option
3Y Returns8.49%
Edelweiss Flexi Cap Fund - Regular Plan - Growth Option
3Y Returns17.36%
Nippon India Multi Asset Allocation Fund - Regular Plan - Growth Option
3Y Returns15.6%
Motilal Oswal Multi Asset Fund - Regular Plan - Growth Option
3Y Returns1.69%
Franklin India Debt Hybrid Fund - Growth
3Y Returns9.03%
Franklin India Debt Hybrid Fund - Growth
3Y Returns9.03%
ITI Value Fund Regular - Growth
3Y Returns17.42%
ICICI Prudential Value Discovery Fund - Growth
3Y Returns20.62%